Koshinski Asset Management, Inc. Kaleido Biosciences, Inc. Transaction History

Koshinski Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$1.3 - $2.7 $780 - $1,620	-600 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$2.39 - $6.02 $478 - $1,204	200 Added 50.0%	600 $1.43 Million
Q3 2021 Oct 12, 2021	BUY	$5.36 - $7.99 $2,144 - $3,196	400 New	400 $2,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Koshinski Asset Management, Inc. with notifications on news.